Skip to main content
Equibles

SNY · Sanofi

Track SNY — free

Use SNY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SNY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$40.04 +0.12 (+0.30%)
Rebalance outlook locked
Market Cap
$98.51B
Shares
2.40B
Volume · Oct 2 4.34M Avg daily vol (3M) 2.9M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$39.92 Open$39.58 Day$39.50–40.07 52W close$39.92–52.34 Avg vol 30d2.6M Short int9.3M · 0.4% float · 4.3d Short vol52% Last earningsOct 28, 2027 DataJan 2020–Oct 2026

Up next

Next earnings call
Oct 30, 2026 Scheduled · in 4 wks
Q4 2025 earnings call transcript
call held Jan 29, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+6.2%
Year over year
Operating margin
14.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$12.83B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-2.4%
Year over year · fewer shares
Price change (1Y)
-20.4%
Trailing year
Short interest
0.4%
Latest settlement · 4.3 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Limited Quant / Vol Very Low
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −11%
below
Price vs 50-day avg −8%
below
RSI (14) 29
oversold
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −10%
trailing
6-month return −15%
trailing
YTD return −18%
this year
Relative strength −27%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $43 › 200d $45 — 200d above 50d
Institutional flow Distributing
5 of 723 funds reported for Sep 30 · net -1.4K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.39% of float · ▲ +12.9% MoM · 4.3 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
723 holders — mid 3-yr range
Squeeze score 41
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very Low
Volatility 23%
annualized · 1-yr
Max drawdown −24%
past year
ATR 1.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−11% Bearish
Price vs 50-day avg
−8% Bearish
RSI (14)
29 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $43 › 200d $45 — 200d above 50d
Institutional flow Distributing
5 of 723 funds reported for Sep 30 · net -1.4K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.39% of float · ▲ +12.9% MoM · 4.3 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
723 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $40 Now $40 · 0% Range high $52
vs 200-day avg -11% vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - General — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SNY
Sanofi
this stock
$98.51B -17.6% — — 0.4%
LLY
ELI LILLY & Co
 $1.11T +6.3% +44.7% 39.7 0.8%
JNJ
Johnson & Johnson
 $653.61B +23.7% +6.0% 31.5 0.9%
ABBV
AbbVie Inc.
 $466.80B +15.0% +8.6% 74.6 1.1%
MRK
Merck & Co., Inc.
 $367.07B +37.1% +1.3% 119.0 1.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
723
% held
8.1%
Reported
5 of 723
Top holder
Dodge & Cox
Held Float
View
Held by Funds
Fund positions
101
View
Short & Settlement
Short Interest Rising
Shares short
9.3M
Days to cover
4.3d
Change
+1.1M sh
View
Short Volume
Short vol %
52%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
103
Value
$4.6K
As of
Sep 8, 2026
View
Off-Exchange
Off-exchange %
46.3%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Sep 11, 2025
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 1, 2026
This year
33
View
Earnings & Events
Webcasts Upcoming
Next webcast
Oct 30, 2026
Last webcast
Jul 30, 2026
View
Investor Relations
Upcoming events
5
View

Performance

5D 20D 120D MTD YTD
SNY -2.9% -10.0% -15.0% -3.2% -17.6%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -2.7% -9.5% -27.2% -4.1% -30.5%
Key facts CIK 1121404 CUSIP 80105N105 13F (30d) 13 filings 11 filers Visit website Investor relations